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  Objective(s): Morphine dependence (MD) potently protects heart against ischemia reperfusion (IR) 
injury through specific signaling mechanisms, which are different from the pathways involved in 
acute morphine treatment or classical preconditioning. Since opioid receptor density changes post 
cerebral ischemia strongly correlated with brain histological damage, in the present study, we 
tried to elucidate the possible role of opioid receptors in IR injury among morphine-dependent 
mice. 
Materials and Methods: Accordingly, incremental doses (10 mg/kg/day to 30 mg/kg/day) of 
morphine sulphate were subcutaneously administered for 5 days before global brain ischemia 
induction through bilateral common carotid artery occlusion. Animals were received naloxone (5 
mg/kg) or L-NAME (20 mg/kg) 30 min after the last morphine dose. Twenty four hr after the 
ischemia induction, Retention trial of passive avoidance test and western blot analysis were done. 
histological analysis (TUNEL and NISSL staining) performed 72 hr after ischemia. 
Results: MD improved post ischemia memory performance (P<0.01) and neuronal survival 
(P<0.001) and decreased apoptosis (P<0.05) in region I of hippocampus (CA1 region) in mouse. 
Treatment with naloxone or L-NAME abolished all MD aforementioned effects. 
Conclusion: Results of the present study suggested that opioid receptors activation in the early hr 
post ischemia is crucial for MD-induced hippocampus tolerance against IR injury. Opioid receptor-
dependent balance of NO production was another key factor in MD-induced protection. Further 
studies are required to determine the effect of MD on opioid receptor changes after ischemia and 
its correlation with MD-induced protection.   
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Introduction 
Brain ischemia is becoming a main cause of 
morbidity and mortality world-wide (1), (2). Global 
brain ischemia induces neuronal cell death, 
especially in vulnerable CA1 pyramidal cells (3). 
Therefore, innovative treatment strategies to protect 
the brain against ischemic injury will improve 
clinical outcomes. One of the important approaches 
is exploitation of endogenous ability of brain to 
“condition” itself against severe ischemia (4). In this 
context, ischemic preconditioning (IPC) is defined as 
brief episodes of ischemia which can protect brain 
from subsequent severe ischemic insult (5-6). 
Detailed mechanistic study of this phenomenon has 
indicated that different pharmacological compounds 
can mimic IPC and induce an equally effective form 
of neuroprotection through activation of similar 
signalling pathways (7-8). In addition, it is possible 
to directly stimulate related end-effectors or activate 
general processes by affecting the metabolism, 
protein synthesis, ATP-sensitive potassium channels 
(KATP) and other involved targets (9-10). The main 
advantage of pharmacological preconditioning in 
comparison with IPC-like interventions is its clinical 
feasibility (11).  
Pharmacological preconditioning can afford 
strong protection of CA1 neurons against ischemic 
hallenge (12). Several in vivo and in vitro studies 
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have been conducted to evaluate the effect of morphine 
and other opioid receptor agonists in limiting the 
harmful effects of ischemia-reperfusion injury. 
Morphine, in an in vitro model of anoxia-reoxygenation, 
markedly improved mitochondrial respiratory activity 
and inhibited alterations in mitochondrial membrane 
fluidity and lipoperoxidation and blocked the enhanced 
release of cytochrome c and subsequent neural cell 
apoptosis (13-14). Treatment with delta- opioid 
receptor agonist or specific delta-opioid receptor-1 
agonist reduced IR-induced neural damage. Morphine 
reduced cerebral infarct size and prevented short-term 
memory impairment. These effects are actually 
abolished by pre-ischemic treatment with KATP 
channel blocker (glibenclamide) or naloxone (15-16).  
Previously, Peart and Gross showed that 5 days 
pre-treatment with implanted morphine pellets 
could produce a profound increase in cardiac tissue 
tolerance against ischemia, even during 24 hr of 
morphine withdrawal period (17). Similarly, chronic 
morphine treatment was effective in heart 
preconditioning among aged mice while acute opioid 
treatment had no effect (18). Further evaluation 
suggested that morphine dependence acts through 
specific signalling pathways, which are different 
from mechanisms in acute morphine treatment or 
classical preconditioning (19). Conversely, our recent 
studies on rat kidney confirmed opioid receptors and 
nitric oxide (NO) involvement in morphine-
dependence induction of protection through the 
same pathways of classical preconditioning (20, 21).  
Although acute morphine protection against 
ischemic brain injury is a dose-dependent and well 
studied phenomenon (22), chronic use of morphine to 
prevent neuronal injury following cerebral ischemia 
has not been investigated up to now. Moreover, 
different opioid receptor subtypes endure changes post 
ischemia. This finding correlates with histological 
damage to the brain tissue (23-25). Based on the 
aforementioned data, we tried to examine the role of 
opioid receptors in MD-induced neuroprotection. 
Recent study on kidney ischemia model has shown that 
MD protects kidney through balancing post ischemia 
NO levels (21), therefore here, possible involvement of 
NO pathway was also evaluated. 
 
Material and Methods 
Animals and experimental protocol 
Eighty male BALB/c mice (prepared from Razi 
institute, Karaj, Iran) weighting 25-30 g maintained 
on a standard laboratory conditions with the free 
access to water tap and chow. Experimental 
procedures confirmed by ethics committee of Tehran 
University of Medical Sciences and National institute 
of health (NIH) guide for the care and use of 
laboratory animals. Animals equally divided into 8 
groups as follows:   
- Sham: 5 days subcutaneous (SC) normal saline 
administration without bilateral common carotid 
arteries occlusion (BCCO) 
- IR (Ischemia Reperfusion): 5 days  normal saline 
administration (SC), 30 min global brain ischemia   
- MD+Sham: 5 days  morphine administration (SC) 
prior to sham operation 
- MD+IR:  5 days  morphine administration (SC) 
followed by 30 min global brain ischemia  
- Nal+IR: 5 days  normal saline administration (SC) 
followed by 30 min global brain ischemia, Naloxone 
(non-selective opioid receptor antagonist) (5 
mg/kg) injection 30 min before surgical procedure 
- MD+ Nal +IR:  5 days morphine administration 
(SC) followed by 30 min global brain ischemia, 
naloxone (5 mg/kg) injection 30 min after the last 
morphine dose 
- L-NAME+IR: 5 days  normal saline administration 
(SC) followed by 30 min global brain ischemia,              
L-NAME (50 mg/kg) injection 30 min before 
surgical procedure  
- MD+L-NAME+IR: 5 days morphine administer-
ation (SC) dose followed by 30 min global brain 
ischemia L-NAME (50 mg/kg) injection 30 min 
after the last morphine dose 
 
In all groups global brain ischemia followed by 24 
hr (n=6) or 72 hr (n=4) reperfusion period. 
 
Drugs and reagent 
The following drugs were used: morphine sulfate 
(Tolid-daru, Tehran, Iran), naloxone (Temad, Tehran, 
Iran), ketamine (Temad, Tehran, Iran) and xylazine 
(Temad, Tehran, Iran). Morphine was dissolved in 
saline; all drug solutions were prepared immediately 
before administration. Ketamine and xylazine were 
administrated intraperitoneally (IP). Morphine and 
naloxone were administered subcutaneously (SC). 
 
Morphine dependence 
Mice were morphine dependent by subcutaneous 
morphine sulphate administration for 5 consecutive 
days. Briefly during the first 4 days morphine was 
injected twice a day (day 1&2: 10 m/kg, day 3&4:           
15 mg/kg; 8 am and 8 pm). The last morphine dose 
(30 mg/kg) was injected 4 hr before ischemia 
induction. This method has already been validated in 
rat model of morphine dependence (20).  Naloxone 5 
mg/kg or L-NAME (50 mg/kg) were administered 30 
min after the last morphine dose and 3.5 hr before 
ischemia induction.   
 
Global brain ischemia reperfusion 
Four hr after the last morphine injection, mice 
were lightly anesthetized using mixture of ketamine 
(50 mg/kg) and xylazine (10 mg/kg). A midline 
incision was made along the neck to expose the left 
and right common carotid arteries followed by vagus 
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nerve release from the surrounding tissues.  Both 
common carotid arteries were carefully dissected 
away from the vagus and encircled with 6-0 suture to 
enable later occlusion with microsurgery clips. When 
animals were semiconscious, bilateral carotid 
arteries were occluded by an arterial clamp for 
global cerebral ischemia induction which was 
confirmed by animal loss of consciousness, eyeball 
whitening and mydriasis. Half an hr later, clamps 
were removed and the incision was closed in layers. 
Mice in each group were subjected to 24 hr 
reperfusion for protein expression and enzymatic 
activity assessments (n=6) or 72 hr for histological 
evaluations (n=4). Body temperature was monitored 
during the surgical procedure using a rectal probe 
and maintained at 36 ± 0.5°C (26). 
 
Behavioural experiment 
Passive avoidance test (PAT) 
Passive avoidance test was done using the shuttle 
box consisting two compartments of light and dark 
with a guillotine door between. The floor was 
covered with stainless steel grids placed at 1 cm 
intervals. Intermittent electric shocks (50 Hz, 1 sec, 
0.5 mA intensity) were delivered to the black 
compartment grid floor by an insulated stimulator. 
First, animals were habituated to the experimental 
conditions. Each animal was then gently placed in the 
light compartment equipped with an electric bulb. 
After 5 sec, the guillotine door was retracted and the 
animal was allowed to enter the dark compartment. 
Animals that waited more than 100 sec to cross were 
excluded from the study. Once the animal crossed 
with all four paws to the next compartment, the 
guillotine door was closed and the animal returned 
to the home cage after 10 sec (habituation trial). The 
acquisition trial was performed 30 min after the 
habituation trial. The animal was placed in the light 
compartment and 5 sec later the guillotine door was 
opened. As soon as the animal crossed to the dark 
compartment, the door was closed and a foot shock 
(50 Hz, 1 sec, 0.5 mA) was immediately induced. 
Retention trial was performed 24 hr after acquisition 
trial and ischemic lesion without applying electric 
shock. The time that animal spent in the light 
compartment before crossing to the dark 
compartment was measured as latency time and 
compared between different groups.  
 
Histological analyses 
Three days after global brain ischemia, animals 
were deeply anesthetized and transcardially 
perfused with 20 ml PBS (0.1 molar, pH 7.4) followed 
by 50 ml of chilled paraformaldehyde (4%) in PBS. 
Brains were then removed and post-fixed in 4% 
paraformaldehyde overnight. After dehydration in 
graded concentration of ethanol and butanol, brains 
were first embedded in paraffin and then cut into 7 
µm- thick serial sections. Neuronal cell loss was 
assessed by histological examination of the dorsal 
hippocampus (CA1 region) of brain sections stained 
with Cresyl Violet. Intact pyramidal neurons in             
CA1 region was counted under a light microscope 
(Olympus, Hamburg, Germany) at 400× 
magnification. Four sections were counted in area of 
53500 µm2 in each mouse. 
To detect DNA fragmentation in degenerating 
neurons and find an index for apoptotic cell death, 
sections were processed for TUNEL nuclear staining 
using an in situ cell death detection kit                        
(Roche Molecular Biochemicals kit, Germany). 
Briefly, sections were deparaffinised and treated 
with proteinase K solution. To block endogenous 
peroxidase activity, sections were incubated in 3% 
H2O2 for 10 min, re-incubated in TUNEL Reaction 
Buffer for 10 min, and then incubated in TUNEL 
Reaction Mixture for 1 hr at 37-40C in humidified 
chamber. Finally, the tissue sections were incubated 
with 0.05% 3, 3-diaminobanzidine (DAB) substrate 
for 1-2 min to visualize apoptotic cells and 
counterstained with Gill's hematoxylin for 30 sec 
(27). Apoptotic cells were observed under light 
microscope with 400X magnification (Olympus, 
Hamburg, Germany). Positive Controls were 
provided through incubating the sections with 
DNAase (3000U/ml in 50 mM Tris-HCl, pH 7.5, 1 
mg/ml BSA) for 10 min at 15°C to induce DNA strand 
breaks prior to labelling procedure. Negative 
Controls were also prepared through incubating the 
sections only with label solution (without terminal 
transferase) instead of TUNEL reaction mixture (27). 
 
Western blot analysis 
To measure Bcl-2 and Bax proteins expression, 
animals were deeply anesthetized 24 hr post global 
brain ischemia. Brain was immediately removed 
from the skull, and hippocampus was dissected. The 
hippocampus was rapidly frozen by immersion in 
liquid nitrogen before being sealed into vials and 
stored at -70°C. Tissue samples were lysed in RIPA 
lysis buffer (#9806, Cell Signalling Technology, Italy) 
on ice for 30 min and centrifuged at 13000 g for 20 
min at 4°C. Protein concentration was determined by 
spectrophotometric method. Loading buffer was 
added to the samples and boiled for 5 min at 95°C. 
Then, they were run on 10% sodium dodecyl sulfate 
polyacrylamide gels and transferred to nitrocellulose 
membrane. Membranes were blocked with 5% milk 
in Tris-buffered saline with Tween (TBST) for 1 hr 
and incubated with primary antibodies including β-
actin [Abcam; β-actin (ab8226), as loading control, 
Cell Signalling Technology, Italy], anti-Bax [#2772, 
Rabbit polyclonal antibody for BAX, Cell Signalling 
Technology, Italy] and anti-Bcl-2 [#2876, Rabbit 
polyclonal antibody for Bcl-2, Cell Signalling 
Technology, Italy] at 4°C overnight. Membranes were  
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Figure 1. Latency time in PAT (Mean±SE, n=10) in different groups. 
Ischemia reperfusion (IR), morphine dependence (MD), Naloxone 
(Nal). One-way ANOVA followed by post-hoc Tucky test to compare the 
mean latency time between groups. ## P<0.01 and ### P<0.001 vs. IR 
group and *P<0.05 and ** P<0.01 vs. MD+IR group 
 
then washed and incubated with the HRP-conjugated 
anti-mouse secondary antibody [#7072, Cell Signalling 
Technology, Italy] for 1 hr at room temperature in the 
dark and scanned for analysis of the relative level of 
each protein expression to β-actin expression. 
 
Statistical analysis 
Results were expressed as mean ± SEM. Analysis 
was performed using SPSS statistical software, 
version 16.0. All data were analyzed by One-
way Analysis of variance (ANOVA), followed by post 
hoc Tukey’s test for between-group comparisons. 
P<0.05 considered to be statistically significant. 
 
Results 
Effect of morphine dependence on memory 
performance 
Passive avoidance test was done for all 
experimental groups to determine the effects of 
ischemic injury and interventions on learning and 
memory performance. As shown in Figure 1, mean 
latency time in the retention trial significantly 
decreased after IR (57.33±15.3; P<0.01 vs Sham). 
Morphine dependence did not change it in sham 
operated animals but it increased latency time post 
ischemia (147±20.03, P<0.05 vs IR). Naloxone by 
itself had no effect on post ischemia memory 
performance, but in morphine dependent group it 
decreased latency time (60.15±18.26, P<0.05 vs 
MD+IR). Latency time in L-NAME treated group 
significantly decreased compared with MD+IR group 
(78.03±10.57, P<0.01 vs. MD+IR). 
 
Histological assessment 
TUNEL staining was applied 72 hr post ischemia 
to examine DNA fragmentation in neurons 
undergoing post ischemia apoptosis. Three sections 
from each hippocampus and from each section,                
one visual field was observed under light microscope 
(400X). The ratio of apoptotic to the total                  
cell number in the visual field represented as the 
apoptotic cell percentage. TUNEL positive cells were 
detected very rarely in the hippocampal sections of 
sham operated groups (Figure 2 A). IR induced a 
dramatic increase in the number of dark brown 
TUNEL-positive CA1 neurons (75.6 ± 4.1%, P<0.001 
vs. Sham, Figure 2 B and H). Morphine dependence 
significantly decreased DNA fragmentation post IR 
(39±2.3%, P<0.05 vs IR, Figure 2 C and H). Naloxone 
by itself had no effect on neuronal cell apoptosis post 
ischemia, but it abolished morphine dependence 
protective  effect on decreased neuronal cell 
apoptosis (67.9±2.6%, P< 0.05 vs MD+IR, Figure 2 D, 
E and H). L-NAME pre-treatment decreased 
morphine dependence neuroprotective effect (62.5 ± 
3.2%, P< 0.05 vs. MD+IR, Figure 2 F, G and H).    
 
 
 
 
Figure 2. Effects of morphine dependency on ischemia-induced apoptosis of hippocampal CA1 neurons. Representative pictures 
of sham (A), IR (B), MD+IR (C), Nal+ IR (D),MD+ Nal+ IR (E), L-NAME+IR (F) and MD+L-NAME+IR (G) 72 hr after ischemia 
(400×). Black arrows are indicating intact cells and red arrows indicating apoptotic cells. Data has been expressed as (Mean± 
SEM). One-way ANOVA followed by Ttucky test was applied to compare the mean percentage of apoptosis between groups. # 
P<0.05 and ### P<0.001 vs. IR group and *P<0.05 vs. MD+IR group (H) 
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Figure 3. Effect of morphine dependency on ischemia-induced neuronal cell loss. Representative pictures of sham (A), IR (B), MD+IR (C), 
Nal+ IR (D), MD+ Nal+ IR (E), L-NAME+IR (F) and MD+L-NAME+IR (G) 72 hr after ischemia (400×). Black arrows are indicating intact cells 
and red arrows indicating necrotic cells. Data has been expressed as the number of counted live hippocampal CA1 neurons (Mean± SEM). 
Statistical analysis for cell density was done using one-way ANOVA followed by Tucky test (Mean± SEM) (H). ## P<0.01 and ### P<0.001 
vs. IR group and **P<0.01 and *** P<0.001 vs. MD+IR group 
 
 
After 72 hr reperfusion, brains were fixed with 
paraformaldehyde (4%). Coronal sections were 
prepared from paraffinized brains and were stained 
with Cresyl Violet. Then the viable neurons in                 
CA1 region were counted. Pyramidal cells of CA1 
region in sham group had normal arrangement, 
round shape, transparent conformation and intact 
nuclei (Figure 3 A). In contrast, 72 hr post ischemia, 
most CA1 pyramidal cells were shrunken (viable 
cells ratio = 20.5 ± 2.2%, P<0.001, Figure 3 B and H), 
however MD increased viable cell number (58.6 ± 
3.8%, P<0.01 vs. IR, Figure 3 C and H). Naloxone 
(25.2 ± 4.6%, P< 0.01 vs. MD+IR, Figure 3 D, E and H) 
and L-NAME (24.4 ± 3.8%, P< 0.01 vs. MD+IR, Figure 
3 F, G and H) decreased viable cell number in 
morphine dependent mice. 
 
Bcl-2 and bax protein expression  
Protein expression has been normalized to β-actin 
expression in each sample and showed as protein 
expression to β-actin expression ratio. Expression of 
pro-apoptotic protein Bax and anti-apoptotic protein 
Bcl-2 significantly increased 24 hr post ischemia 
(P<0.05 vs Sham, Figure 4). Morphine dependence 
decreased the expression of Bax protein and increased 
Bcl-2 protein expression 24 hr post ischemia (P<0.05 
vs. IR, Figure 4). Noloxone administration before 
ischemia blocked the effect of morphine dependence on 
Bax and Bcl-2 protein expression (P<0.05 and P<0.01 
vs. MD+IR, respectively, Figure 4).  L-NAME by itself 
could not change the expression of Bax or Bcl-2 post 
ischemia, but abolished the effect of morphine 
dependence on expression of Bax and Bcl-2 (P<0.05 vs. 
MD+IR, Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Expression of pro-apoptotic protein Bax and anti-apoptotic protein Bcl-2 in samples prepared from hippocampal tissue after treatment. 
The results show the ratio of Bax or Bcl-2 protein expression to β-actin expression (upper panel). Data are shown as Mean ± SEM. Ischemia 
reperfusion (IR), morphine dependence (MD), Naloxone (Nal). One-way ANOVA followed by post-hoc Tucky test was applied to compare the mean 
rate of protein expression between groups.  # P<0.05 and ## P<0.01 vs. IR group. *P<0.05 and **P<0.01 vs. MD+IR group 
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Discussion 
Finding new molecular mechanisms to increase 
vital organs tolerance against ischemia is the point of 
interest among basic scientists and clinicians. The 
first ideas of tissue preconditioning through 
induction of morphine dependence in animals comes 
from the studies on heart that showed morphine 
dependence potentiated protection via specific 
molecular mechanisms that are different from the 
classical preconditioning pathways(17-19).   
In the present study, we set out to clarify the 
morphine dependence potential role in brain tolerance 
against ischemia and contribution of opioid receptors 
and NO in MD-induced ischemia protection. Results of 
the behavioural studies confirmed the effect of 
morphine dependence on preserving memory 
performance after global brain ischemia. Biochemical 
and histological experiments showed that MD 
decreased oxidative stress, apoptotic cell death in CA1 
region and increased cell survival after ischemia. These 
effects were abolished in naloxone or L-NAME treated 
groups and suggested opioid receptors and NO 
contributions in MD induced protection. Same results 
have been obtained in kidney model of ischemia (21).  
 
Morphine dependence improves post ischemia 
memory  
According to Motamedi and et al, morphine 
dependence effects on rat learning and memory             
is a task-dependent phenomenon and cannot 
significantly affect passive avoidance test outcomes 
(30). In the present study, memory performance in 
morphine dependent mice is similar to the sham 
group, which confirms that the present protocol of 
dependence does not affect memory in normal mice. 
However, it affects post ischemia memory formation 
through increasing latency time in PAT (Figure 1). 
Biochemical and histological evaluations show that 
the PAT results in MD mice are correlated with 
improved tissue damage in this group.  
 
Morphine dependence effects on post ischemia 
neuronal cell survival  
CA1 neurons loss was seen 2-4 days post global 
cerebral ischemia, and lasted for weeks (3, 31). In the 
present study, hippocampus slices were prepared          
3 days post ischemic insult, when the CA1 neuronal 
loss reached its peak. Morphine dependence 
significantly increased live neurons in CA1 region 72 
hr post ischemia (Figure 3). In a recent study, Dong 
et al, showed that morphine treatment (1 mg/kg,            
60 min before ischemia) decreased neuronal 
degeneration, number of apoptotic cells and caspase-
3 expression in rats. Increasing morphine dose to 7 
mg/kg strongly decreased pathological changes and 
number of apoptotic cells and caspase-3 expression 
(22, 32).  Our results showed that TUNEL positive 
cells were markedly reduced in ischemic brains 
prepared from morphine dependent mice compared 
to vehicle-treated control mice (Figure 2). Apoptosis 
maximally occurs 72 hr post ischemia. This is due to 
the anti- and pro- apoptotic proteins changes in 
primary phases of reperfusion (31). Therefore we 
preferred to prepare samples for protein expression 
after 24 hr of reperfusion. Ischemia reperfusion 
increased the expression of Bax and Bcl-2. Increased 
Bcl-2 expression might be a compensatory 
mechanism against apoptosis. Morphine dependence 
decreased Bax expression and Bax/Bcl-2 ratio but 
increased Bcl-2 expression and CA1 neuronal 
survival 72 hr post ischemia.  
Cell survival and death is strictly related to the 
oxidative state because it interacts with cellular 
macromolecules and signalling pathways.  Reactive 
oxygen species (ROS) through macromolecules 
oxidation act as a trigger for apoptotic pathways 
(33). Increased ratio of Bax/Bcl-2 expression after 
ischemia reperfusion could be related to of ROS 
production, which reflected in increased MDA level, 
and decreased anti-oxidative mechanisms including 
SOD and catalase activities.  These results are 
concomitant with limited neuronal cell death and 
improved Bax/Bcl-2 ratio in the morphine 
dependent group. 
 
Role of opioid receptors 
Single dose naloxone administration before 
ischemia affected all protective aspects of morphine 
dependence including behavioural test, neuronal            
cell loss apoptosis and oxidative state. Interestingly, 
these findings suggest that opioid receptors activation 
just before ischemia is crucial to express protective 
effects of chronic morphine use against ischemia. In 
cardiac models of ischemia, cardioprotective effects of 
δ1-opioid receptor agonist have been abolished by δ1-
opioid antagonist administration either 30 min before 
or 48 hr after receptor activation (34). In kidney model 
of ischemia, naloxone administration just before 
ischemia also abolished protective effects of chronic 
morphine use (20, 21). 
Boutinet et al, have previously reported early 
changes in different opioid receptors subtypes after 
focal cerebral ischemia in different sub-cortical 
regions in mice (24). Delta and mu opioid receptors 
density in the cortex of mice were decreased 6 h 
after middle cerebral artery occlusion (MCAO) which 
was correlated with later histological damage (25). 
Therefore opioid receptors activation in the early 
phases after ischemia seems to be crucial in ischemia 
injury outcome. In the present work, naloxone by 
itself had no effect on the ischemic injury but it 
affected varying degrees of protection afforded by 
chronic morphine use. This may suggest that 
reoccupation of opioid receptors in the first hr after 
ischemia is crucial for morphine dependence to be 
effective against hippocampus ischemic damage.   
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On the other hand, protective effects of chronic 
morphine use both in cardiac and renal tissues lasted 
even 24 hr after the last morphine dose (17, 21). In 
the present study, samples for biochemical and 
histological studies have been prepared 24 and 72 hr 
after the last morphine dose, and their results 
confirmed the morphine dependence persisting 
effect even after 3 days. Boutinet et al also found that 
opioid receptors underwent changes at later phases 
after ischemia. Utilizing the quantitative 
autoradiography method, they showed that mu, delta 
and kapa opioid receptor expressions have been 
decreased in the ipsilateral cortex one day after 
MCAO and stayed low up to 7 days after ischemia 
which is correlated with strong histological damage 
(23). Although we did not quantify opioid receptors 
density during reperfusion, these data strongly 
suggest that both acute and late signalling 
mechanisms involved in MD induced protection are 
opioid receptor dependent.  
 
Balanced NO production as a key element in MD 
induced neuroprotection 
NO role in brain ischemia reperfusion injury, like 
other organs is a matter of controversy. Some studies 
have proved its cytotoxicity while others reported 
NO as one of the key signalling factors in brain 
preconditioning against ischemia (35, 36). This 
controversy mainly relates to the enzymatic source 
and tissue level of NO (35, 37).  In the present study, 
treatment with L-NAME in morphine dependent 
group suppressed post ischemia NO production and 
all mentioned morphine protective effects. So L-
NAME increased apoptotic cell death and Bax/Bcl-2 
ratio of CA1 region. These findings also focused on 
NO crucial role in protective effects of chronic 
morphine use against ischemia reperfusion injury.  
Altogether, the results suggested that chronic 
morphine treatment before global cerebral ischemia 
decreased IR induced hippocampal tissue damage, 
apoptosis and memory deficits through the opioid 
receptors and NO dependent pathways.  
 
Conclusion 
Considering the role of opioid receptors on 
neuroprotection, their post ischemic density and 
function changes and protective effects on tissue 
damage outcomes, recent data of morphine 
dependence-induced preconditioning may provide 
important insights on molecular mechanisms 
involved in pharmacological neuroprotection. 
Accordingly, chronic morphine use despite its minus 
social and cultural features can be considered as an 
alternative for neuroprotective implications. 
Moreover, based on morphine dependence 
protective role in cerebral ischemia, we should 
follow the safe and feasible ways of using this 
method to protect the brain from other acute and 
chronic neuronal disorders. 
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